Guanylpiperidine peptidomimetics: potent and selective bis-cation inhibitors of factor Xa.
暂无分享,去创建一个
R. Nutt | S. Tamura | J. Ho | J. E. Semple | T. Brunck | O. Levy | E. Goldman | R F Nutt | J E Semple | S Y Tamura | O E Levy | T H Uong | J E Reiner | E A Goldman | J Z Ho | C R Cohen | P W Bergum | T K Brunck | T. Uong | J. Reiner | C. R. Cohen | P. Bergum | J. Semple | John E. Reiner | Jonathan Z Ho | Cheryl R. Cohen | Peter W. Bergum | Ruth F. Nutt
[1] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[2] J. Morrison,et al. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions , 1982 .
[3] H. Kunz,et al. Diastereoselective Strecker Synthesis of α‐Aminonitriles on Carbohydrate Templates , 1987 .
[4] R. Colman,et al. Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 1988 .
[5] K. Mann,et al. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.
[6] H. Kunz,et al. Carbohydrates as chiral templates: diastereoselective Ugi synthesis of (S)-amino acids using O-acylated D-arabinopyranosylamine as the auxiliary , 1989 .
[7] R. Huber,et al. Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.
[8] G. Vlasuk. Structural and Functional Characterization of Tick Anticoagulant Peptide (TAP): A Potent and Selective Inhibitor of Blood Coagulation Factor Xa , 1993, Thrombosis and Haemostasis.
[9] Steven H. Huang,et al. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Nutt,et al. Novel and general method for the preparation of peptidyl argininals , 1996 .
[11] R. Nutt,et al. Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties. , 1996, Journal of medicinal chemistry.